Clinical Trial Update: Plan Development for Giving Teclistamab in the Outpatient Setting [Phase 4]

View source ↗

Summary

Plan development for delivering teclistamab to patients with relapsed/refractory multiple myeloma in the outpatient setting as part of a Phase 4 trial; recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Multiple Myeloma, Relapsed Cancer | Phase 4 | Status: RECRUITING